Literature DB >> 14727452

IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease.

A Hamzaoui1, H Ghraïri, J Ammar, S Zekri, F Guemira, K Hamzaoui.   

Abstract

OBJECTIVE: IL-18 expression and functional activity has been identified in several autoimmune and infectious diseases. To clarify the potential role of IL-18 during pulmonary Behçet's disease (BD), we have explored the capacity of IL-18 to induce the expression of IFN-gamma.
METHODS: We studied bronchoalveolar lavage (BAL) from 12 patients with BD, 10 patients with silicosis as the control disease and 10 BAL from healthy subjects. BAL fluid, and BAL fluid cell cultures were investigated for IL-18 estimation by ELISA. Analysis of IL-18 and IFN-gamma gene expression was carried out before and after LPS stimulation.
RESULTS: BD patients had significantly elevated levels of IL-18 in BAL fluid compared with control disease and healthy subjects. Induction of IFN-gamma and IL-18 were observed from BD-BAL fluid cells both spontaneously and after LPS stimulation, at higher levels compared to silicosis patients and healthy subjects (HC). Spontaneously only BD BAL cells expressed IL-18 mRNA and IFN-gamma mRNA. Forty-eight hours after LPS stimulation IL-18 mRNA and IFN-gamma mRNA were observed in BD, silicosis and HC cells. Recombinant IL-18 induced IFN-gamma production in BD- BAL fluid cells.
CONCLUSION: Administration of IL-18 induced greater IFN-gamma production in BD-BAL fluid cells, than in normal BAL fluid cells. Our data indicate that IL-18 up-regulation is a feature of BD and suggest that IL-18 and IFN-gamma may contribute to the local inflammatory response in BD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14727452

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  12 in total

1.  Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.

Authors:  H Nagafuchi; M Takeno; H Yoshikawa; M S Kurokawa; K Nara; E Takada; C Masuda; M Mizoguchi; N Suzuki
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

2.  Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?

Authors:  Salih Pay; Hakan Erdem; Aysel Pekel; Ismail Simsek; Ugur Musabak; Ali Sengul; Ayhan Dinc
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

3.  Serum interleukin-18 levels in patients with Behçet's disease. Is its expression associated with disease activity or clinical presentations?

Authors:  U Musabak; S Pay; H Erdem; I Simsek; A Pekel; A Dinc; A Sengul
Journal:  Rheumatol Int       Date:  2005-10-05       Impact factor: 2.631

Review 4.  Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.

Authors:  Noboru Suzuki; Kazuhiko Nara; Tomoko Suzuki
Journal:  Clin Med Res       Date:  2006-06

Review 5.  Immunopathogenesis of Behçet's disease with special emphasize on the possible role of antigen presenting cells.

Authors:  Salih Pay; Ismail Simşek; Hakan Erdem; Ayhan Dinç
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

6.  Release of B cell-activating factor of the TNF family in bronchoalveolar lavage from Behçet's disease with pulmonary involvement.

Authors:  Agnès Hamzaoui; Hanene Chelbi; Fayçal Hai Sassi; Kamel Hamzaoui
Journal:  Oxid Med Cell Longev       Date:  2010 Mar-Apr       Impact factor: 6.543

7.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

8.  NOD2 is highly expressed in Behçet disease with pulmonary manifestations.

Authors:  Kamel Hamzaoui; Hanadi Abid; Anissa Berraies; Jamel Ammar; Agnès Hamzaoui
Journal:  J Inflamm (Lond)       Date:  2012-02-13       Impact factor: 4.981

9.  Pulmonary manifestations in Behçet disease: impaired natural killer cells activity.

Authors:  Kamel Hamzaoui; Anissa Berraies; Wajih Kaabachi; Jamel Ammar; Agnès Hamzaoui
Journal:  Multidiscip Respir Med       Date:  2013-04-04

10.  Tc1/Tc2 ratio in the inflammatory process in patients with Behçet's disease.

Authors:  Habib Houman; Agnes Hamzaoui; Imed Ben Ghorbal; Monia Smiti Khanfir; Moncef Feki; Kamel Hamzaoui
Journal:  Mediators Inflamm       Date:  2004-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.